MedTrace Logo

Comparison of Desensitizing Materials

NCT04527159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-09-01

No results posted yet for this study

Summary

To compare the efficacy of two commercially available in-office desensitizing agents (Fluoraphat Pro and VivaSens®), in the treatment of dentinal hypersensitivity.

Conditions

  • Dentin Hypersensitivity

Interventions

DRUG

Fluoraphat Pro / VivaSens

desensitizing agents for treatment of dentinal hypersensitivity

Sponsors & Collaborators

  • Nourah Mulfi Aljasser

    lead OTHER

Principal Investigators

  • Roula Alboouni, Prof · Riyadh Elm University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-06
Primary Completion
2019-03-30
Completion
2020-02-24

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04527159 on ClinicalTrials.gov